Interview with Dr Bruce Cuthbert - RDoC and its influence on 21st century psychiatric drug discovery

No satisfactory theory of the pathophysiology of mental disorders has been uncovered. Despite years of research, we still do not have enough of an understanding of the biological mechanisms of psychopathology to be able to move towards prevention or cure of mental disorders. A radical proposal to tackle this failure is the National Institute of Mental Health (NIMH) Research Domain Criteria (RDoC) initiative.

At the 30th international CINP congress in Seoul, Korea, we spoke with Dr Bruce Cuthbert, Acting Director of the NIMH, about the RDoC initiative and how it can support improved research into CNS disorders and their management.

RDoC is a new research framework for studying mental disorders. The framework consists of a matrix of functional constructs - concepts which represent specified dimensions of behaviour. These are characterized by many levels of information (from genomics to self-report). Constructs are grouped into higher-level domains of functioning - major systems of emotion, cognition, motivation and social behaviour. A key feature of RDoC is that it is a dynamic initiative - the matrix can be expanded with new research discoveries as these become available.

Dr Bruce Cuthbert described the overarching goal of RDoC - to understand mental disorders as deviations from the normal functioning of brain systems, rather than continuing with inadequate symptom-based definitions. We don’t yet know what an integrated multi-measurement diagnostic system looks like. Therefore, RDoC is not an alternative nosology - rather, it is a focused research initiative moving towards a new classification system.

Sign up for our newsletter to stay up to date with latest updates


Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Le informazioni contenute nel nuovo sito prescelto possono non essere conformi al D.Ivo 219/06 che regola la pubblicità dei medicinali per uso umano e le opinioni espresse non riflettono necessariamente le posizioni dell’azienda, non sono da essa avvallate.
Accesso riservato a Operatori Sanitari
Per accedere si prega di registrarsi o, in caso sia già stato fatto, di autenticarsi
L’accesso a Progress in Mind Italia è consentito unicamente agli Operatori Sanitari (medici e farmacisti). I contenuti di questo sito sono prodotti da un team di Operatori Sanitari il cui obiettivo è presentare le ultime novità in ambito psichiatrico e neurologico, attraverso interviste, registrazioni audio/video di seminari con opinion leader, report e sintesi di congressi sia internazionali che nazionali. Per poter accedere al sito è quindi necessario registrarsi e fornire alcuni dati così da poter verificare che l‘utente sia un Operatore Sanitario.
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Register for access to Progress in Mind in your country